Page results
- 
                                    
                                                                            The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH. 
- 
                                    
                                                                            Bones marrow harvest patient information page. 
- 
                                    
                                                                            This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS). 
- 
                                    
                                                                            Health and wellbeing information for people affected by cancer. 
- 
                                    
                                                                            This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing 
- 
                                    
                                                                            This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH. 
- 
                                    
                                                                            Patient information on managing pain 
- 
                                    
                                                                            This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure. 
- 
                                    
                                                                            Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH. 
- 
                                    
                                                                            This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH). 
File results
- 
                                                                            FOI/2022/0209 - Patient tracking list or waiting lists 
- 
                                                                            FOI/2022/0211 - Enteral feeding machine mechanical insufflator 
- 
                                                                            FOI/2022/0212 - Clotting disorders medication 
- 
                                                                            FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311 
- 
                                                                            FOI/2022/0217 - Medications for dermatological conditions 
- 
                                                                            FOI/2022/0221 - Asthma medications 
- 
                                                                            FOI/2022/0223 - Policies/ procedures for management of patients with chest pain 
- 
                                                                            FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services 
- 
                                                                            FOI/2022/0226 - Treatments for Haemophilia A 
- 
                                                                            FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust